408 related articles for article (PubMed ID: 23108540)
1. The evolution and comparative neurobiology of endocannabinoid signalling.
Elphick MR
Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3201-15. PubMed ID: 23108540
[TBL] [Abstract][Full Text] [Related]
2. Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release.
Lee SH; Ledri M; Tóth B; Marchionni I; Henstridge CM; Dudok B; Kenesei K; Barna L; Szabó SI; Renkecz T; Oberoi M; Watanabe M; Limoli CL; Horvai G; Soltesz I; Katona I
J Neurosci; 2015 Jul; 35(27):10039-57. PubMed ID: 26157003
[TBL] [Abstract][Full Text] [Related]
3. The phylogenetic distribution and evolutionary origins of endocannabinoid signalling.
Elphick MR; Egertová M
Handb Exp Pharmacol; 2005; (168):283-97. PubMed ID: 16596778
[TBL] [Abstract][Full Text] [Related]
4. Brain regional cannabinoid CB(1) receptor signalling and alternative enzymatic pathways for 2-arachidonoylglycerol generation in brain sections of diacylglycerol lipase deficient mice.
Aaltonen N; Riera Ribas C; Lehtonen M; Savinainen JR; Laitinen JT
Eur J Pharm Sci; 2014 Jan; 51():87-95. PubMed ID: 24012970
[TBL] [Abstract][Full Text] [Related]
5. The neurobiology and evolution of cannabinoid signalling.
Elphick MR; Egertová M
Philos Trans R Soc Lond B Biol Sci; 2001 Mar; 356(1407):381-408. PubMed ID: 11316486
[TBL] [Abstract][Full Text] [Related]
6. Endocannabinoids and Their Pharmacological Actions.
Pertwee RG
Handb Exp Pharmacol; 2015; 231():1-37. PubMed ID: 26408156
[TBL] [Abstract][Full Text] [Related]
7. Opposing local effects of endocannabinoids on the activity of noradrenergic neurons and release of noradrenaline: relevance for their role in depression and in the actions of CB(1) receptor antagonists.
Kirilly E; Hunyady L; Bagdy G
J Neural Transm (Vienna); 2013 Jan; 120(1):177-86. PubMed ID: 22990678
[TBL] [Abstract][Full Text] [Related]
8. Why do cannabinoid receptors have more than one endogenous ligand?
Di Marzo V; De Petrocellis L
Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3216-28. PubMed ID: 23108541
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of the CB1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus.
Ludányi A; Eross L; Czirják S; Vajda J; Halász P; Watanabe M; Palkovits M; Maglóczky Z; Freund TF; Katona I
J Neurosci; 2008 Mar; 28(12):2976-90. PubMed ID: 18354002
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid signalling in the enteric nervous system.
Galligan JJ
Neurogastroenterol Motil; 2009 Sep; 21(9):899-902. PubMed ID: 19689654
[TBL] [Abstract][Full Text] [Related]
11. Noncanonical Activity of Endocannabinoids and Their Receptors in Central and Peripheral Synapses.
Balezina OP; Tarasova EO; Gaydukov AE
Biochemistry (Mosc); 2021 Jul; 86(7):818-832. PubMed ID: 34284706
[TBL] [Abstract][Full Text] [Related]
12. Localization of CiCBR in the invertebrate chordate Ciona intestinalis: evidence of an ancient role for cannabinoid receptors as axonal regulators of neuronal signalling.
Egertová M; Elphick MR
J Comp Neurol; 2007 Jun; 502(4):660-72. PubMed ID: 17428001
[TBL] [Abstract][Full Text] [Related]
13. Endocannabinoid-mediated retrograde modulation of synaptic transmission.
Ohno-Shosaku T; Kano M
Curr Opin Neurobiol; 2014 Dec; 29():1-8. PubMed ID: 24747340
[TBL] [Abstract][Full Text] [Related]
14. VGluT3-expressing CCK-positive basket cells construct invaginating synapses enriched with endocannabinoid signaling proteins in particular cortical and cortex-like amygdaloid regions of mouse brains.
Omiya Y; Uchigashima M; Konno K; Yamasaki M; Miyazaki T; Yoshida T; Kusumi I; Watanabe M
J Neurosci; 2015 Mar; 35(10):4215-28. PubMed ID: 25762668
[TBL] [Abstract][Full Text] [Related]
15. CB₂ cannabinoid receptors inhibit synaptic transmission when expressed in cultured autaptic neurons.
Atwood BK; Straiker A; Mackie K
Neuropharmacology; 2012 Sep; 63(4):514-23. PubMed ID: 22579668
[TBL] [Abstract][Full Text] [Related]
16. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
[TBL] [Abstract][Full Text] [Related]
17. Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia.
Nyilas R; Gregg LC; Mackie K; Watanabe M; Zimmer A; Hohmann AG; Katona I
Eur J Neurosci; 2009 May; 29(10):1964-78. PubMed ID: 19453631
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the endocannabinoid system, CB(1) receptor signalling and desensitization in human myometrium.
Brighton PJ; Marczylo TH; Rana S; Konje JC; Willets JM
Br J Pharmacol; 2011 Nov; 164(5):1479-94. PubMed ID: 21486283
[TBL] [Abstract][Full Text] [Related]
19. An introduction to the endocannabinoid system: from the early to the latest concepts.
De Petrocellis L; Di Marzo V
Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):1-15. PubMed ID: 19285257
[TBL] [Abstract][Full Text] [Related]
20. Untapped endocannabinoid pharmacological targets: Pipe dream or pipeline?
Wilkerson JL; Bilbrey JA; Felix JS; Makriyannis A; McMahon LR
Pharmacol Biochem Behav; 2021 Jul; 206():173192. PubMed ID: 33932409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
